So great to get some insights about this from @SeoyoungCKim for @RheumNow:
https://t.co/Snj8pejT7U
While we're all a bit disappointed about the possibility of safety issues for one of our brightest, most important Rx, better with info that helps us understand and mitigate #ACR21
Links:
Tofacitinib and Malignancy Risk: Dr. Seoyoung Kim | RheumNow
https://rheumnow.com/video/tofacitinib-and-malignancy-risk-dr-seoyoung-kim
10-11-2021